|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 47/48 | (2006.01) |
| A61K 31/704 | (2006.01) | ||
| A61K 31/4995 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1827500 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05803151.9 |
| Date of filing the European patent application | 2005-10-26 | |
| (97) | Date of publication of the European application | 2007-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2009-05-06 |
| (46) | Date of publication of the claims translation | 2009-08-25 |
| (86) | Number | PCT/GB2005/050189 |
| Date | 2005-10-26 |
| (87) | Number | WO 2006/046080 |
| Date | 2006-05-04 |
| (30) | Number | Date | Country code |
| 622163 P | 2004-10-26 | US |
| (72) |
GILLES, Erard, US
STERNAS, Lars-Axel, US
TRIFAN, Ovid, US
VAN DE VELDE, Helgi, BE
TEITELBAUM, April, US
|
| (73) |
Pharma Mar S.A., Sociedad Unipersonal,
Polígono Industrial La Mina Avda. de los Reyes, 1 Colmenar Viejo, 28770 Madrid,
ES
Ortho Biotech Products L.P., 700 Us Highway 202, Raritan NJ 08869, US |
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pegilintas liposominis doksorubicinas derinyje su ekteinescidinu 743 |
| PEGYLATED LIPOSOMAL DOXORUBICIN IN COMBINATION WITH ECTEINESCIDIN 743 |
| Payment date | Validity (years) | Amount | |
| 2016-10-04 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2016-10-04 |